TAZ anticorps (AA 1-100)
-
- Antigène Voir toutes TAZ Anticorps
- TAZ (Tafazzin (TAZ))
-
Épitope
- AA 1-100
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp TAZ est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Réactivité croisée
- Humain, Souris, Rat
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human TAZ
- Isotype
- IgG
- Top Product
- Discover our top product TAZ Anticorps primaire
-
-
- Indications d'application
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Date de péremption
- 12 months
-
-
Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells." dans: Journal of cellular biochemistry, Vol. 117, Issue 6, pp. 1419-28, (2016) (PubMed).
: "Prognostic impact of TAZ and ?-catenin expression in adenocarcinoma of the esophagogastric junction." dans: Diagnostic pathology, Vol. 9, pp. 125, (2014) (PubMed).
: "
-
Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells." dans: Journal of cellular biochemistry, Vol. 117, Issue 6, pp. 1419-28, (2016) (PubMed).
-
- Antigène
- TAZ (Tafazzin (TAZ))
- Autre désignation
- TAZ (TAZ Produits)
- Synonymes
- anticorps wu:fb39f12, anticorps zgc:91803, anticorps MGC54019, anticorps TAZ, anticorps taz, anticorps GB11956, anticorps Afu2g13960, anticorps BTHS, anticorps CMD3A, anticorps EFE, anticorps EFE2, anticorps G4.5, anticorps LVNCX, anticorps Taz1, anticorps 5031411C02Rik, anticorps 9130012G04Rik, anticorps AW107266, anticorps AW552613, anticorps tafazzin, anticorps tafazzin L homeolog, anticorps tafazzin homolog, anticorps TAZ, anticorps taz, anticorps taz.L, anticorps LOC550948, anticorps AFUA_2G13960, anticorps AOR_1_318014, anticorps Tsp_06712, anticorps Taz
- Sujet
-
Synonyms: TAZ, WW domain-containing transcription regulator protein 1, Transcriptional coactivator with PDZ-binding motif, WWTR1
Background: Transcriptional coactivator which acts as a downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. WWTR1 enhances PAX8 and NKX2-1/TTF1-dependent gene activation. Regulates the nuclear accumulation of SMADS and has a key role in coupling them to the transcriptional machinery such as the mediator complex. Regulates embryonic stem-cell self-renewal, promotes cell proliferation and epithelial-mesenchymal transition.
- ID gène
- 25937
- UniProt
- Q9GZV5
-